Literature DB >> 8082356

The prevalence and response to therapy of Strongyloides stercoralis in patients with asthma from endemic areas.

J H Wehner1, C M Kirsch, F T Kagawa, W A Jensen, A C Campagna, M Wilson.   

Abstract

STUDY
OBJECTIVE: To evaluate the prevalence and response to therapy of Strongyloides stercoralis infection in immigrant patients with asthma from areas endemic for Strongyloides. DESIGN AND
INTERVENTIONS: In all patients, we performed a complete history and physical examination, complete blood cell counts (CBC), S stercoralis serologic tests, spirometry, and evaluated three stool samples for ova and parasites. Patients treated for S stercoralis infection had follow-up CBC, spirometry, serologic tests, and at least three additional stool examinations to confirm eradication of the parasite.
SETTING: Ambulatory and hospitalized patients who were referred to the respiratory medicine clinic of a general hospital for the evaluation and treatment of asthma. PATIENTS: Forty-five asthmatic adults, representing 12 endemic countries, ranging in age from 20 to 76 years, were prospectively evaluated.
RESULTS: Six of 45 patients were infected with S stercoralis, which yielded a prevalence of 13 percent. The patients with asthma and S stercoralis infection had higher blood eosinophil counts (p = 0.006) and were younger (p = 0.006) compared with patients with only asthma. There was no difference in the duration of asthma, spirometry, or steroid use between the two groups. Patients with S stercoralis and asthma tended to be more recent immigrants (p = 0.05). Five of the six patients with S stercoralis agreed to be treated with thiabendazole but only four returned for follow-up evaluation. All four patients had eradication of S stercoralis infection confirmed by negative stool examinations and a decline in S stercoralis serology (160 +/- 25 percent vs 13 +/- 13 percent, p = 0.03). All four patients had a decline in total blood eosinophil counts (2,476 +/- 832 cells per cubic millimeter vs 551 +/- 138 cells per cubic millimeter, p = 0.03) without a clinical improvement in asthma.
CONCLUSIONS: Our data suggest that patients with asthma from areas endemic for S stercoralis, who have elevated peripheral blood eosinophil counts, should be screened for S stercoralis infection. Successful eradication of S stercoralis, however, may not result in a clinical improvement of asthma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082356     DOI: 10.1378/chest.106.3.762

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Serologic Monitoring of Public Health Interventions against Strongyloides stercoralis.

Authors:  Paola Vargas; Alejandro J Krolewiecki; Adriana Echazú; Marisa Juarez; Pamela Cajal; Jose F Gil; Nicolás Caro; Julio Nasser; Patrick Lammie; Rubén O Cimino
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

2.  Infection with Strongyloides venezuelensis induces transient airway eosinophilic inflammation, an increase in immunoglobulin E, and hyperresponsiveness in rats.

Authors:  Micheline R Silveira; Kênia P Nunes; Denise C Cara; Danielle G Souza; Ary Corrêa; Mauro M Teixeira; Deborah Negrão-Corrêa
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey.

Authors:  David R Boulware; William M Stauffer; Brett R Hendel-Paterson; Jaime Luís Lopes Rocha; Raymond Chee-Seong Seet; Andrea P Summer; Linda S Nield; Khuanchai Supparatpinyo; Romanee Chaiwarith; Patricia F Walker
Journal:  Am J Med       Date:  2007-06       Impact factor: 4.965

4.  Wait!!! No Steroids for this Asthma….

Authors:  Abdelhamid Alsharif; Amik Sodhi; Luis C Murillo; Arthur S Headley; Dipen Kadaria
Journal:  Am J Case Rep       Date:  2015-06-26

Review 5.  Strongyloidiasis: Risk and Healthcare Access for Latin American Immigrants Living in the United States.

Authors:  Graciela Ostera; James Blum
Journal:  Curr Trop Med Rep       Date:  2016-02-03

6.  Pulmonary strongyloidiasis causing septic shock in a patient with Crohn's disease.

Authors:  Mohammed Abdalla; Pavel Sinyagovskiy; Wiam Mohamed; Amro Abdelghani
Journal:  Respir Med Case Rep       Date:  2018-04-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.